Exploring Bioinformatics Tools to Analyze the Role of CDC6 in the Progression of Polycystic Ovary Syndrome to Endometrial Cancer by Promoting Immune Infiltration
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms252312974 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Yuhang Song und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Basic Medicine, Xinjiang Medical University, Urumqi 830054, China. Hauptthemen laut MEDLINE: Polycystic Ovary Syndrome, Endometrial Neoplasms, Cell Cycle Proteins, Computational Biology. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 80 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the National Natural Science Foundation of China, National Natural Science Foundation of China.
Abstract (Originalsprache)
Cell division cycle 6 (CDC6) is essential for the initiation of DNA replication in eukaryotic cells and contributes to the development of various human tumors. Polycystic ovarian syndrome (PCOS) is a reproductive endocrine disease in women of childbearing age, with a significant risk of endometrial cancer (EC). However, the role of CDC6 in the progression of PCOS to EC is unclear. Therefore, we examined CDC6 expression in patients with PCOS and EC. We evaluated the relationship between CDC6 expression and its prognostic value, potential biological functions, and immune infiltrates in patients with EC. In vitro analyses were performed to investigate the effects of CDC6 knockdown on EC proliferation, migration, invasion, and apoptosis. CDC6 expression was significantly upregulated in patients with PCOS and EC. Moreover, this protein caused EC by promoting the aberrant infiltration of macrophages into the immune microenvironment in patients with PCOS. A functional enrichment analysis revealed that CDC6 exerted its pro-cancer and pro-immune cell infiltration functions via the PI3K-AKT pathway. Moreover, it promoted EC proliferation, migration, and invasion but inhibited apoptosis. This protein significantly reduced EC survival when mutated. These findings demonstrate that CDC6 regulates the progression of PCOS to EC and promotes immune infiltration.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Basic Medicine, Xinjiang Medical University, Urumqi 830054, China.
- School of Clinical Medicine, Xinjiang Medical University, Urumqi 830054, China.
- Department of Immunology, School of Basic Medicine, Central South University, Changsha 410017, China.
- Basic Medical College, Xinjiang Medical University, Urumqi 830054, China.
ORCID-Profile: Yao Li
Förderung
- the National Natural Science Foundation of China
- National Natural Science Foundation of China
Zitieren
APA
Song, Y., Zhang, J., Li, Y., Cheng, L., Song, H., Zhang, Y., Du, G., Yu, S., Zou, Y., & Xu, Q. (2024). Exploring Bioinformatics Tools to Analyze the Role of CDC6 in the Progression of Polycystic Ovary Syndrome to Endometrial Cancer by Promoting Immune Infiltration. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms252312974
Vancouver
Song Y, Zhang J, Li Y, Cheng L, Song H, Zhang Y, et al. Exploring Bioinformatics Tools to Analyze the Role of CDC6 in the Progression of Polycystic Ovary Syndrome to Endometrial Cancer by Promoting Immune Infiltration. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms252312974
BibTeX
@article{Song2024,
author = {Song, Yuhang and Zhang, Jing and Li, Yao and Cheng, Lufeng and Song, Hua and Zhang, Yuhang and Du, Guoqing and Yu, Sunyue and Zou, Yizhou and Xu, Qi},
title = {Exploring Bioinformatics Tools to Analyze the Role of CDC6 in the Progression of Polycystic Ovary Syndrome to Endometrial Cancer by Promoting Immune Infiltration},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms252312974}
}
EUVIMED